Mark Stejbach, MBA

Academic Affiliate,
Life Sciences Expert

Send a message


Virginia Tech (BS)

Wharton Business School (MBA)


Mark Stejbach is a life sciences expert. 

Mark Stejbach is a commercial biotech / pharma executive with over 35 years of experience ranging from private startup to Fortune 100 companies. He has held leadership roles in marketing, sales, market development, managed care, investor relations and business development.

Board experience:

  • Chair of the Compliance, Ethics & Sustainability Committee
  • Member of the Audit & Risk Committee
  • Member of the Nomination Committee
  • Member of the Science Committee

Relevant Experience

  • INDIVIOR, Richmond, VA  2021-Present
    Global specialty pharmaceutical company developing and marketing treatments for substance use disorder and serious mental illness
    -Board of Directors, Committee assignments: Audit & Risk Committee; Science; Compliance, Ethics & Sustainability (Chair)
    -Chair newly created CES committee to oversee management and reporting of compliance, ESG, and government reporting activities
  • FLEXION THERAPEUTICS, Burlington, MA 2016-2021
    Publicly-traded specialty biopharma company focused on musculoskeletal conditions
    -Board of Directors, Audit Committee
    -Designated Audit Committee contact for corporate compliance and partnered with legal team on initiation of first commercial compliance program
  • ALKERMES, Waltham, MA 2012-2018
    -Management committee and leader of all commercial operations
  • TENGION, INC., East Norriton, PA 2008–2012
    -Responsible for marketing, business development, public affairs, HR, and IT functions of fully integrated company pursuing autologous organ and tissue regeneration
  • MERCK & CO., INC., Whitehouse Station, NJ 1997–2008
    -Vice President, Managed Care Marketing
    -Senior Director, Investor Relations


Virginia Tech (BS)
Wharton Business School (MBA)

AlixPartners’ professionals work closely with several Academic Affiliates who bring deep subject matter expertise in niche areas of economics, financial accounting, and corporate governance.